Company Filing History:
Years Active: 2012-2015
Title: Unveiling the Innovations of Inventor Gary Lee Larson
Introduction:
Gary Lee Larson, a talented inventor hailing from Cypress, CA (US), has made remarkable contributions to the field of pharmaceuticals with his innovative patented compounds.
Latest Patents:
1. N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators: Larson's invention focuses on a compound that affects voltage-gated potassium channels, with potential applications in treating seizure disorders.
2. Derivatives of 4-(n-azacycloalkyl) anilides as potassium channel modulators: This compound, designed by Larson, can also modulate potassium channels, offering promising avenues for treating various diseases influenced by these channels.
Career Highlights:
Larson is associated with Valeant Pharmaceuticals International, where his innovative spirit and dedication have flourished. His two patents showcase his expertise in developing medications that target specific ion channels in the body.
Collaborations:
Throughout his career, Larson has collaborated with esteemed individuals in the field, such as Jean-Michel Andre Vernier and Huanming Chen. Together, they have worked towards advancing pharmaceutical research and development.
Conclusion:
Inventor Gary Lee Larson's groundbreaking work in the pharmaceutical industry exemplifies his commitment to creating solutions for complex medical conditions. His patents serve as a testament to his ingenuity and dedication to improving healthcare outcomes.